BioVie Inc (BIVI)

[someconcerns]

Just so we choke off debate about something which did not happen, here is a repeat of a post regarding NNAB from the CT** board:

BigKahuna Wednesday, 02/04/15 08:31:57 AM
Re: JUST 10-11-12 post# 90284
Post # of 90323

We must not confuse KARD Scientific with CTIX. KARD is a CRO as well as research and development company whose founder and lead researcher was Krishna Menon the same person who founded and is President of CTIX. At one point, all of the drugs developed by KARD ultimately were licensed to CTIX. Some examples include Prurisol and Kevetrin as well as KM 391 and KM 277. Rajah Menon, the president and director of NNAB, is listed as a founder of KARD Scientific.

When Rajah Menon and Elliot Ehrlich founded NNAB, CTIX's officers say CTIX had no interest in antibiotics, so KARD's various licenses for antibiotics went to NNAB. In the meantime, according to Leo and Krishna Menon, Elliot and Rajah learned of Polymedix demise and the action for its IP by the bankruptcy trustee. NNAB was not in a position to acquire all of Polymedix and so they took the opportunity to their fathers at CTIX. The successful stalking horse bid became what we refer to today as the Polyheist.

Bottom line, NNAB licensed its preclinical antibiotic candidates to NNAB when CTIX was itself struggling to get Prurisol and Kevetrin into clinical stage development.

I think BigKahuna meant "CTIX or KARD Licensed" instead of "NNAB licensed" in the last sentence of the quote.